Description
Treviamet Tablets (50 mg + 1000 mg, 35’s) are a combination medication specifically designed for the management of type 2 diabetes mellitus. Each tablet contains Sitagliptin (50 mg) and Metformin (1000 mg), which work together to enhance blood sugar control. Sitagliptin is a DPP-4 inhibitor that stimulates the pancreas to produce more insulin in response to meals, while Metformin decreases glucose production in the liver and improves insulin sensitivity. This dual-action approach is particularly effective when used alongside a balanced diet and regular exercise. Treviamet is indicated for patients whose diabetes is not adequately controlled by lifestyle changes alone. It is essential to adhere to the prescribed dosage and consult a healthcare professional for personalized guidance. Common side effects may include gastrointestinal discomfort, but these are generally mild and temporary.
